-

Spring Bank Class Action: Halper Sadeh LLP Announces Filing of Shareholder Class Action Lawsuit Against Spring Bank Pharmaceuticals, Inc.; Investors Are Encouraged to Contact the Firm - SBPH

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, announces the filing of a shareholder class action lawsuit against Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH) in connection with its merger with F-star Therapeutics Limited. The lawsuit seeks damages and/or equitable relief on behalf of Spring Bank shareholders under the federal securities laws.

If you are a Spring Bank shareholder and would like to join the action, visit Spring Bank Class Action or contact Daniel Sadeh or Zachary Halper, free of charge, at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com to discuss your legal rights and options.

Under the terms of the share exchange agreement, Spring Bank will acquire all of the outstanding share capital of F-star in exchange for the issuance of newly issued shares of Spring Bank common stock (the “Proposed Transaction”). Spring Bank shareholders will own approximately 38.8% of the combined company.

The lawsuit alleges that Defendants issued a materially incomplete and misleading registration statement recommending that Spring Bank shareholders vote in support of the Proposed Transaction. According to the complaint, the registration statement contains materially incomplete and misleading information concerning, among other things, Spring Bank’s and F-star’s financial projections and the analyses performed by Spring Bank’s financial advisor.

If you wish to serve as lead plaintiff, you must move the Court no later than November 27, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you would like to join the action, visit https://halpersadeh.com/actions/spring-bank-pharmaceuticals-inc-sbph-stock-merger-fstar/ or contact Daniel Sadeh or Zachary Halper, free of charge, at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com to discuss your legal rights and options.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE OR YOU MAY REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Halper Sadeh LLP

NASDAQ:SBPH

Release Versions

Contacts

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

More News From Halper Sadeh LLP

AVO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Mission Produce, Inc. is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Mission Produce, Inc. (NASDAQ: AVO) and Calavo Growers, Inc. is fair to Mission shareholders. Upon completion of the proposed transaction, Mission shareholders are expected to own approximately 80.3% of the combined company. Halper Sadeh encourages Mission shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212)...

CVGW Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Calavo Growers, Inc. is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Calavo Growers, Inc. (NASDAQ: CVGW) to Mission Produce, Inc. for $14.85 in cash and 0.9790 shares of Mission for each share of Calavo is fair to Calavo shareholders. Halper Sadeh encourages Calavo shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com....

Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) breached their fiduciary duties to shareholders. If you currently own BioXcel stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about...
Back to Newsroom